GlobeNewswire by notified

Correction: Agillic announces its financial results for Q3 2023 showing a 13% increase in ARR from Subscriptions, a 1% decrease in Total ARR and a positive EBITDA of DKK 3.5m

Share

Announcement no. 14 2023

Copenhagen - 12 October 2023

Correction to company announcement no 13 regarding the financial guidance table.

The Total ARR in the guidance table should have stated DKK 70-77 million (the sum of ARR Subscriptions and ARR Transactions) in alignment with the guidance announced on 23rd August 2023. The information has been corrected in the statement below.

Copenhagen – 12 October 2023 – Agillic A/S (Nasdaq First North Growth Market Denmark: AGILC) releases its financial results for Q3 2023. EBITDA increased to DKK 3.5 million (up 3.8 million vs. Q3 2022) while ARR from subscription increased 13% YoY to DKK 56.8 million.

Emre Gürsoy, CEO of Agillic comments

“We are very pleased to have delivered double digit growth in ARR from subscriptions and a positive EBITDA in Q3. This is a result of our continued focus on operational excellence and sustainable growth, while we also focus on growing our international markets based on a scalable international business model and future readiness through a ready-to-integrate best-of-breed platform. As we announced in August, global price increases on SMS transactions have led to a decline in ARR from transactions resulting in an overall decline in Total ARR of -1% YoY.”

Key figures and ratios

2023202220232022
DKK millionYTDYTDChangeQ3Q3Change
INCOME STATEMENT
Revenue subscriptions 40.2 36.4 11% 13.6 13.1 4%
Revenue transactions 9.1 10.7 -15% 3.0 4.8 -37%
Other revenue 0.0 0.4 -100% 0.0 0.0 -100%
Total revenue 49.3 46.5 6% 16.6 17.0 -2%
Gross profit  39.6 34.1 16% 13.4 11.4 18%
Gross margin 80% 72% 12% 81% 67% 21%
Employee costs -23.5 -23.3 1% -6.4 -7.3 -12%
Operational costs -12.6 -11.2 12% -4.5 -2.7 66%
EBITDA 3.5 -0.3 n/a 2.5 1.4 79%
Net profit -5.1 -8.6 -41% -0.4 -1.2 -67%
FINANCIAL POSITION
Cash 11.5 1.8 539% 11.5 1.8 539%
ARR DEVELOPMENT
ARR subscriptions 56.8 50.3 13% 56.8 50.3 13%
ARR transactions 12.1 19.6 -38% 12.1 19.6 -38%
Total ARR 68.9 69.9 -1% 68.9 69.9 -1%
Change in ARR (DKK) 2.5 5.7 2.5 5.7
Change in ARR % 4% 9% 4% 9%


Financial guidance 2023

Agillic maintains its financial guidance as announced 23 August 2023:

DKK million2023
Revenue 67-70
EBITDA 1-4
ARR Subscriptions 56-60
ARR Transactions 14-17
Total ARR 70-77

Strategy going forward
We will continue to execute our Reboot 2.1 strategy with focus on internationalisation through a two-pronged go-to-market model, and cooperation with best-of-breed technology partners and global solution partners. Apart from Denmark, markets of particular interest are the DACH region, Norway, and Sweden. Our target clients are digitally mature and data-driven B2C-businesses in industries such as retail, finance, travel & leisure, NGO and charities, and subscription businesses in e.g. entertainment & gaming, energy and utilities, media & publishing, and technology & software.

Live online presentation
CEO Emre Gürsoy and CFO Claus Boysen will present the Q3 financial results on 12 October at 11.00 am CET in a live online presentation. You can already now send in questions and sign up for the event.
Sign up via this link: Agillic Presentation of financial results for Q3 2023.
A recording of the presentation will be available same place.

For further information, please contact:
Emre Gürsoy, CEO, Agillic A/S
+45 30 78 42 00
emre.gursoy@agillic.com

Claus Boysen, CFO, Agillic A/S
+45 28 49 18 46
claus.boysen@agillic.com

Certified Adviser
John Norden, Norden CEF A/S

Disclaimer
The forward-looking statements regarding Agillic’s future financial situation involve factors of uncertainty and risk, which could cause actual developments to deviate from the expectations indicated. Statements regarding the future are subject to risks and uncertainties that may result in considerable deviations from the presented outlook. Furthermore, some of these expectations are based on assumptions regarding future events, which may prove incorrect. Please also refer to the overview of risk factors in the ‘risk management’ section of the annual report.

About Agillic A/S

Agillic is a Danish software company offering brands a platform through which they can work with data-driven insights and content to create, automate and send personalised communication to millions. Agillic is headquartered in Copenhagen, Denmark, with teams in Germany, Norway, and Romania.

For further information, please visitwww.agillic.com

Agillic A/S (publ) (Nasdaq First North Growth Market Denmark: AGILC) is obligated to publish the above information in compliance with the EU Market Abuse Regulation Article 17.

The information was published via agent by Agillic A/S on 12 October 2023.

Appendix: Financial development per quarter

202320222021
DKK millionQ3Q2Q1Q4Q3Q2Q1Q4Q3Q2Q1
INCOME STATEMENT
Revenue subscriptions 13.6 13.5 13.1 13.4 12.2 12.2 11.1 10.8 11.0 11.9 11.3
Revenue transactions 3.0 2.9 3.2 5.7 4.8 3.3 2.6 2.7 1.8 1.2 1.0
Other revenue 0.0 0 0.0 0.0 0.0 0.1 0.3 0.3 0.3 0.2 0.3
Total revenue 16.6 16.4 16.3 19.1 17.0 15.6 14.0 13.8 13.1 13.3 12.6
Gross profit  13.4 13.2 13.0 15.5 11.4 11.7 11.0 10.7 11.1 12.1 11.2
Gross margin81%80%80% 81% 67% 75% 79% 78% 85% 91% 89%
Employee costs -6.4 -9.7 -7.4 -8.6 -7.3 -8.0 -8.0 -5.5 -6.2 -6.8 -6.9
Operational costs -4.5 -2.5 -5.6 -5.5 -2.7 -3.7 -4.8 -7.7 -4.5 -3.2 -3.6
EBITDA 2.5 1.0 0.0 1.5 1.4 0.0 -1.7 -2.6 0.4 2.2 0.7
Net profit -0.4 -1.8 -2.9 -2.0 -1.2 -2.7 -4.7 -4.6 -3.1 -0.5 -2.3
BALANCE SHEET
Cash1 11.5 18.3 26.9 7.4 1.8 12.6 7.5 20.6 18.6 22.0 23.8
Total assets 64.9 69.0 75.8 60.3 54.0 58.7 55.4 61.6 65.7 69.5 67.2
Equity 1.5 1.8 3.4 -15.0 -13.2 -12.0 -9.6 -4.5 1.0 2.9 3.2
Borrowings 23.0 24.2 25.7 24.3 23.7 26.1 26.4 27.2 28.2 28.6 29.0
CASH FLOW
Cash flow from operations -2.8 -3.1 1.2 6.7 -4.9 9.0 -8.3 6.1 0.0 1.2 -1.6
Cash flow from investments -3.1 -6.5 -3.3 -3.3 -3.3 -3.7 -3.2 -2.0 -3.8 -2.5 -2.8
Cash flow from financing -0.8 -2.3 21.6 2.5 -2.5 -0.3 -1.6 -2.0 0.4 -0.5 11.8
Net cash flow -6.7 -11.9 19.5 5.9 -10.7 5.0 -13.1 2.1 -3.4 -1.8 7.4
EMPLOYEES & CLIENTS
Employees end of period 50 50 46 48 47 51 47 44 47 49 50
Clients end of period 120 120 118 118 111 108 105 97 92 91 86
ARR & SAAS METRICS
ARR subscriptions 56.8 54.9 54.2 54.1 50.3 49.6 48.5 45.7 44.0 43.2 42.4
ARR transactions 12.1 11.5 17.3 22.6 19.6 14.6 10.3 10.0 7.3 4.8 4.2
Total ARR2 68.9 66.4 71.5 76.7 69.9 64.2 58.8 55.7 51.3 48.0 46.6
Change in ARR (DKK) 2.5 -5.1 -5.2 6.8 5.7 5.4 3.1 4.4 3.3 1.4 0.1
Average ARR3 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.5 0.5
Yearly CAC4 0.3 0.3 0.1 0.3
Months to recover CAC5 3 7.8

1. Cash is defined as available funds less bank overdraft withdrawals.
2. ARR, i.e., the annualised value of subscription agreements and transactions at the end of the actual reporting period.
3. Average ARR, i.e. the average Total ARR per client.
4. Customer Acquisition Costs (CAC), i.e., the sales and marketing cost (inclusive salaries, commissions, direct and share of costs of office) divided by the number of new clients. CAC is calculated end of year.
5. Months to recover CAC, i.e., the period in months it takes to generate sufficient gross profit from a client to cover the acquisition cost.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Application to delist from Nasdaq First North Growth Market Denmark submitted24.2.2024 14:17:57 CET | Press release

Copenhagen, Feb. 24, 2024 (GLOBE NEWSWIRE) -- Announcement no. 3-2024 Hypefactors has submitted an official application to delist from Nasdaq First North Growth Market Denmark. A decision backed by 98,42% of the share capital represented at the Extraordinary General Meeting held on 23. February 2024 Delisting requires the final approval from Nasdaq. The details of​ the delisting ​procedure and ​consequenses for shareholders is stated in the company announcement 01-2024. ---- About Hypefactors A/S Hypefactors is an AI based reputation and corporate trust technology company, providing a tech platform to support better media intelligence and reputation/trust management. Hypefactors combine data, analytics, technology, and tools to provide a unified and easy-to-use experience. With all the tools to automate and ease the work, and all the facts to document the results. In addition to media monitoring across the different media channels, the platform provides access to several facts, incl. a

798 Launches Folk Culture Sector of Square Art Festival, 110,000+ Visitors Reached During the Chinese New Year Vacation24.2.2024 03:00:00 CET | Press release

BEIJING, Feb. 24, 2024 (GLOBE NEWSWIRE) -- 798 Art District announces today that the Folk Culture Sector of the 798 Square Art Festival will launch on February 24, 2024, at the CONCERTED SQUARE of 798 Art District in Beijing. This sector aims to bridge contemporary art with urban and rural folk culture. Visiting 798 during the Lantern Festival, you can experience the power of contemporary art intertwined with traditional folk customs and enjoy the familiar yet strange world of Chinese local culture. Event Poster February 24 is the Lantern Festival in China, and it marks the end of the Chinese New Year festivities. The New Year vacation in 798 was full of lively atmosphere. Throughout the Spring Festival, 15 exhibitions were ongoing in 798, including the Joy Art Museum's "Joy in the Year of the Dragon", IOMA Art Center's "Dragon Roaming the World and Prospering", MOCUBE's "Upon Arrival of Dragon", and Le Rime Gallery's "Jia Chen Mountain Chronicle". Based on statistics, there were over

Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®24.2.2024 02:15:00 CET | Press release

SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S. SIMLANDI is the first biosimilar approval under the strategic partnership between Alvotech and Teva in the U.S. market SIMLANDI will qualify for interchangeable exclusivity in the U.S. for some concentration strengths Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the U.S. Food and Drug Administration (FDA) has approved SIMLANDI (adalimumab-ryvk) injection, as an interchangeable biosimilar to Humira, for the treatment of adult rheumatoid arthritis, juvenile idiopathic arthritis, adult psoriatic arthritis, adul Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the U.S. Food and Drug Administration (FDA) has approved SIMLANDI (adalimumab-ryvk) injection, as an interchan

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons23.2.2024 23:50:47 CET | Press release

Company Announcement COPENHAGEN, Denmark; February 23, 2024 –Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) by managerial employees and their closely associated persons. The company’s managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf to publish trading in Genmab shares by the company’s managerial employees and their closely associated persons. Please find below a statement of such trading in shares issued by Genmab A/S 1.Details of the person discharging managerial responsibilities / person closely associateda)NameJan G. J. van de Winkel2.Reason for the notificationa)Position/statusPresident & Chief Executive Officerb)Initial notification/AmendmentInitial notification3.Details of the issuer, emission allowance market participant, auction platform,

Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab23.2.2024 23:35:31 CET | Press release

Company Announcement COPENHAGEN, Denmark; February 23, 2024 –Genmab A/S (Nasdaq: GMAB) announced today that the board decided to grant 418,646 restricted stock units to members of management and employees of the company as well as the company's subsidiaries and 316,899 warrants to employees of the company and the company's subsidiaries. Each restricted stock unit is awarded cost-free and provides the owner with a conditional right to receive one share in Genmab A/S of nominally DKK 1. The vesting of the restricted stock units granted to the members of executive management will, with the exception of deferred annual cash bonus, be subject to forward looking performance criteria and consequently represent the maximum opportunity available if the performance targets have been significantly exceeded. The fair value of each restricted stock unit is equal to the closing market price on the date of grant of one Genmab A/S share, DKK 2,013. The restricted stock units will vest on the first ban

HiddenA line styled icon from Orion Icon Library.Eye